Evaluation of Abuse Potential of Synthetic Cannabinoids and Phytocannabinoids Using In Vivo Pharmacological Studies
ID: 15DDHQ25Q00000010Type: Solicitation
Overview

Buyer

JUSTICE, DEPARTMENT OFDRUG ENFORCEMENT ADMINISTRATIONOFFICE OF DIVERSION CONTROLSPRINGFIELD, VA, 22152, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is soliciting proposals for the evaluation of the abuse potential of synthetic cannabinoids and phytocannabinoids through in vivo pharmacological studies. The procurement aims to assess the risks associated with these substances by conducting various assays, including locomotor activity and drug discrimination studies, over five ordering periods involving a total of 17 drugs. This initiative is part of the federal government's commitment to public health and safety, ensuring informed regulatory decisions regarding substance abuse. Interested contractors should submit detailed pricing proposals, including a breakdown of costs, to Marie Devine at marie.t.devine@dea.gov, with an estimated total cost for the services set at $8,500.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines a funding request for evaluating the abuse potential of synthetic opioids and hallucinogenic substances using in vivo pharmacological studies, as mandated by the Drug Enforcement Administration (DEA). It specifies five ordering periods, each including various assays: locomotor activity and drug discrimination assays, alongside incidental costs associated with training and testing drugs. The document details the pricing structure with individual line items for each assay, emphasizing that testing will involve a total of 17 drugs, comprising 15 test drugs and 2 reference drugs. Each ordering period requires a pricing sheet indicating quantities, unit prices, and total estimated costs, although specific costs were not filled in. This request for proposals (RFP) is part of the federal government’s approach to assess and manage substance abuse through scientific evaluations, reflecting its commitment to public health and safety. The structure of the document suggests a systematic process for evaluating bids from contractors who will execute the specified studies, contributing to a better understanding of the risks associated with certain substances.
    The document outlines a Request for Proposals (RFP) from the Drug Enforcement Administration (DEA) focusing on the evaluation of the abuse potential of synthetic opioids and other depressants. It specifies a list of assay line items, including locomotor activity assays and drug discrimination studies, along with their associated costs. Contractors are required to submit a comprehensive pricing proposal that includes a sample BPA Call Order, adhering to a fixed-rate structure for various assay categories. The estimated total cost for these services is stated as $8,500. The document emphasizes that any proposals lacking complete pricing as outlined in the Sample BPA Call Order will not be reviewed, ensuring that submitted proposals include detailed breakdowns of costs including direct labor, overhead, and administrative expenses. The RFP emphasizes the need for thorough statistical evaluations to gauge the potential abuse of substances, thus guiding regulatory decisions on synthetic opioids and depressants.
    Similar Opportunities
    DESTRUCTION OF PHARMACEUTICALS
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is seeking to award a purchase order for the destruction of pharmaceuticals collected during National Drug Take Back Day. The procurement involves the incineration of 40,000 pounds of pharmaceuticals, with Veolia ES Technical Solutions LLC identified as the sole source capable of performing this service due to its unique capabilities and necessary permits. This initiative is critical for public health and environmental protection, addressing the urgent need for safe disposal of unused drugs to combat opioid abuse. Interested parties can contact Jose Marin at jose.l.marin@dea.gov for further information, with the contract period running from April 29, 2025, to June 30, 2025, and potential additional fees for further disposal needs.
    DEA National Community Outreach and Prevention Engagement
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is seeking sources for the National Community Outreach and Prevention Engagement initiative aimed at combating substance misuse across the United States. The primary objectives include enhancing local responses to drug threats by connecting DEA leadership with communities, increasing awareness of substance misuse issues, and fostering public-private partnerships through community summits, training coalitions, and youth leadership programs. This initiative is part of a broader strategy to integrate public health approaches with law enforcement efforts in addressing drug-related challenges. Interested organizations are encouraged to submit capability statements and can contact Charles Ivy at charles.d.ivy@dea.gov for further information.
    Info-Tech Research Group
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is seeking to engage with Info-Tech Research Group for a federal contract opportunity. This procurement falls under the category of Other Computer Related Services, with a focus on IT and telecom products related to data center facilities, including hardware and perpetual license software. The services are crucial for enhancing the DEA's operational capabilities in managing and analyzing data effectively. Interested vendors can reach out to Randy Bell Sr. at randy.bellsr@dea.gov for further details regarding this opportunity, which is based in Arlington, Virginia.
    Foreign Language Training for DEA
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is seeking qualified contractors to provide foreign language training under a five-year firm fixed-price contract. The objective of this procurement is to enhance the language capabilities of DEA personnel in support of investigations related to drug enforcement and national security, with required languages including Arabic, Chinese, Spanish, among others. The contractor will be responsible for delivering competent instructors, tailored curricula, and training facilities, while adhering to proficiency benchmarks set by the Interagency Language Roundtable (ILR) standards and ensuring compliance with government security measures. Proposals must be submitted by April 4, 2025, and interested parties can contact Ana M. Villanueva at Ana.M.Villanueva@dea.gov for further information.
    Covert Concealment Devices
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is seeking to procure covert audio/video recording devices through a sole source negotiation with Saul Mineroff Electronics, Inc. This procurement aims to fulfill the DEA's specialized requirements for law enforcement equipment, emphasizing the need for advanced covert concealment devices. Interested vendors capable of meeting these specifications are invited to submit capability statements by March 20, 2025, at 10:00 AM EST, with all submissions to be sent electronically to Robert A. Jones at robert.a.jonesjr@dea.gov. This opportunity follows the Simplified Acquisition Procedures outlined in FAR Part 13, and the associated NAICS code is 334290.
    U.S. CBP, San Diego Field Office Narcotics Destruction
    Buyer not available
    The U.S. Customs and Border Protection (CBP) is soliciting quotes for Narcotics Destruction Services at its San Diego Field Office, with a focus on small businesses. The contractor will be responsible for the environmentally safe destruction of approximately 23,000 pounds of seized narcotics, adhering to the Seized Asset Management Enforcement Procedures Handbook and Drug Enforcement Administration regulations. This initiative is crucial for preventing the diversion of controlled substances to illicit activities while ensuring compliance with legal and environmental standards. Interested vendors must submit their quotations via email to Christopher Shaw at christopher.j.shaw@cbp.dhs.gov by the deadline of March 12, 2025, at 10:00 AM PDT, with the contract value estimated at $47.5 million.
    Drug Testing Kits
    Buyer not available
    The Department of Defense, specifically the Marine Corps Recruiting Command (MCRC), is seeking vendors to provide non-instrumental, single-use instant drug test kits for use at Military Entrance Processing Stations (MEPS) across six Marine Corps Districts (MCDs). The procurement aims to supply approximately 477,200 kits over a four-year period, with deliveries occurring quarterly to eight Recruiting Stations (RS) within each district. These drug test kits are crucial for maintaining the integrity of the enlistment process by ensuring accurate and reliable drug screening of applicants. Interested vendors must submit their company information, capabilities, and pricing estimates by the specified deadlines, with the contract anticipated to be awarded in December 2025. For further inquiries, vendors can contact Wellington Shelton at wellington.shelton@usmc.mil or Kacy Mohead at kacy.m.mohead@usmc.mil.
    State of Practice on Oral Fluid Programs
    Buyer not available
    The National Highway Traffic Safety Administration (NHTSA) is seeking qualified contractors to support the development of oral fluid testing programs aimed at addressing drug-impaired driving on U.S. roadways. The primary objective of this procurement is to identify and document existing oral fluid programs, including their implementation practices, benefits, challenges, and legal frameworks across various states, thereby enhancing law enforcement's ability to detect impaired drivers. This initiative is particularly important as current technologies are limited in measuring drug impairment beyond alcohol, amidst rising drug use and changing legalization landscapes. Interested parties can contact Michelle Shanahan at michelle.shanahan@dot.gov or Vincent Lynch at Vincent.Lynch@dot.gov for further information, with the project timeline and specific deliverables outlined in the Draft Statement of Work.
    Raptor Licenses
    Buyer not available
    The Department of Justice, specifically the Drug Enforcement Administration (DEA), is planning a sole source procurement for Raptor Licenses from Sandoval Custom Creations, Inc. (SCCI). This procurement is classified under the NAICS Code 334310, which pertains to Audio and Video Equipment Manufacturing, and is intended to streamline the acquisition process while evaluating vendor capabilities. Interested vendors who believe they can meet the DEA's requirements are invited to submit a capability statement by March 25, 2025, at 10:00 AM EST, although the DEA may choose not to open the procurement to competition. For further inquiries, vendors can contact Robert A. Jones at robert.a.jonesjr@dea.gov or by phone at 571-776-1215.
    THC – Pharmacy Department - Two (2) Pharmacist
    Buyer not available
    The Department of Health and Human Services, specifically the Indian Health Service, is seeking qualified contractors to provide pharmacist services at the Tsaile Health Center in Arizona. The procurement involves supplying two pharmacists for a contract period from May 1, 2025, to April 30, 2028, with contractors responsible for all associated costs and operating independently without government supervision. This opportunity is designated for Indian Small Business Economic Enterprises (ISBEE) under NAICS code 561320, emphasizing the importance of supporting Indian-owned businesses in public procurement. Interested parties must submit their quotes by March 26, 2025, directly to the designated contracting officer, Earl Morris Jr., at earl.morris@ihs.gov, with secondary contact Tanya Begay available at tanya.begay2@ihs.gov for further inquiries.